Denmark, March 13, 2024 (GlobeNewswire) -- The Board of Directors of ChemoMetec appoints current COO Martin Helbo Behrens as new CEO. Mr. Behrens was ChemoMetec's first US COO and has contributed significantly to its high growth.
Read full article here.
Durham, NCÂ and Seattle, WA, January 12, 2025 (Business Wire) -- Tune Therapeutics has raised $175 million in Series B funding to...
Ribometrix Names William S. Marshall, Ph.D., as CEO to Drive Breakthrough RNA-Targeting Therapeutics
Durham, NC, January 09, 2025 (Globe newswire) -- Ribometrix has appointed Dr. William S. Marshall as CEO and Dr. Katie Warner as CSO,...
San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure...
Commentaires